United States · 
Who invested in Abata Therapeutics?
Abata Therapeutics's investors include Lightspeed Venture Partners, Invus and Samsara BioCapital.
United States · Venture startup
Who invested in Abata Therapeutics
Funding summaryUpdated 26 Oct 2026
Undisclosedraised across 1 round since 2024, from 1 source
- Latest round
- VentureAug 2024
- Investors
- 3
The rounds
- Aug 2024
Founders and team
From the SEC filings it signed: 6 on the team.
- Ellen Cahir-McfarlandExecutive Officeri
- John TrzupekExecutive Officeri
- Leonard DragoneExecutive Officeri
- Samantha SingerExecutive Officer, Directori
- Sandy LazzariExecutive Officeri
- Stephen SofenExecutive Officeri
On the board, as filediAbbie CelnikerDavid KaufmanLorence KimMitch FinerNagesh MahanthappaShelley ChuValerie Odegard
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Abata Therapeutics
How much has Abata Therapeutics raised?
Abata Therapeutics has raised 1 round since 2024, none with a disclosed amount.
When did Abata Therapeutics last raise?
Abata Therapeutics's most recent round was a Venture in Aug 2024.
Who backed Abata Therapeutics first?
Abata Therapeutics's first round on record, in Aug 2024, was backed by Lightspeed Venture Partners, Invus and Samsara BioCapital.
What stage is Abata Therapeutics at?
Abata Therapeutics's latest named round is a Venture, in Aug 2024.
Where is Abata Therapeutics based?
Abata Therapeutics is based in the United States.
Companies like Abata Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.